In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SetPoint Medical Corp.

www.setpointmedical.com

Latest From SetPoint Medical Corp.

Start-Up Spotlight: SetPoint Develops Vagus Nerve Stimulation To Treat Crohn's Disease And Rheumatoid Arthritis

SetPoint Medical is developing vagus nerve stimulation technology for Crohn’s disease and rheumatoid arthritis and believes it will be a "platform technology" for treating a variety of autoimmune diseases.

Start-up Spotlight Commercial

SetPoint Taps Intersect's Former BD Exec To Head Commercial Ops

Neuromodulation technology specialist SetPoint Medical has appointed Ankit Shah, whose track record include stints at Intersect ENT and Medtronic, as head of commercialization and marketing.

Inflammation Appointments

SetPoint Medical Starts Testing Unique Neuromodulation Device In Rheumatoid Arthritis Patients

SetPoint Medical announced the launch of a multicenter clinical trial to test its vagus nerve stimulation system in rheumatoid arthritis patients who did not adequately respond to multiple biologic agents. Among the company's backers are Medtronic, Boston Scientific and GSK.

Immune Disorders Inflammation

Pacts In Medtech, Jan/Feb 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech highlights notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we look at industry pacts that were sealed in the first two months of 2018.

Commercial Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Gastrointestinal
  • Inflammation
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Innovative Metabolics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SetPoint Medical Corp.
  • Senior Management
  • Murthy Simhambhatla, PhD, CEO
    David Chernoff, MD, CMO
  • Contact Info
  • SetPoint Medical Corp.
    Phone: (661) 750-6140
    25101 Rye Canyon Loop
    Santa Clarita, CA 91355
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register